Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,009 | 9,509 | 13,673 | 10,495 | 6,821 |
| Marketable Securities | 79,160 | 7,217 | 9,723 | 6,499 | 16,313 |
| Receivables | N/A | N/A | N/A | N/A | 22 |
| Other current assets | 122 | 17 | 33 | 165 | 0 |
| TOTAL | $103,659 | $17,869 | $24,557 | $18,528 | $24,480 |
| Non-Current Assets | |||||
| PPE Net | 51 | 59 | 68 | 77 | 85 |
| Other Non-Current Assets | 634 | 804 | 754 | 754 | 221 |
| TOTAL | $685 | $863 | $822 | $831 | $306 |
| Total Assets | $104,344 | $18,732 | $25,379 | $19,359 | $24,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,001 | 2,897 | 2,797 | 2,700 | 2,607 |
| Accounts payable and accrued liabilities | 1,284 | 1,156 | 1,156 | 965 | 1,007 |
| Accrued Expenses | 3,881 | 3,592 | 3,548 | 4,501 | 2,960 |
| Other current liabilities | 5,862 | 4,343 | 3,279 | 1,145 | 1,177 |
| TOTAL | $14,028 | $11,988 | $10,780 | $9,311 | $7,751 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,809 | 4,599 | 5,362 | 6,098 | 6,809 |
| Other Non-Current Liabilities | 3 | 6 | 10 | 13 | 14 |
| TOTAL | $3,812 | $4,605 | $5,372 | $6,111 | $6,823 |
| Total Liabilities | $17,840 | $16,593 | $16,152 | $15,422 | $14,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,864 | 43,757 | 28,752 | 28,752 | 23,447 |
| Common Shares | 4 | 3 | 3 | 2 | 2 |
| Retained earnings | -445,473 | -437,239 | -428,310 | -422,959 | -416,007 |
| Other shareholders' equity | -13 | -1 | -2 | -1 | -2 |
| TOTAL | $86,504 | $2,139 | $9,227 | $3,937 | $10,212 |
| Total Liabilities And Equity | $104,344 | $18,732 | $25,379 | $19,359 | $24,786 |